The political party in power in Italy, the Brothers of Italy, has proposed a modification to Bill 1038 which seeks to ban the long-distance and cross-border sale of e-cigarettes. However, the proposed amendment failed to gain support from the League party. Instead, the League party introduced a secondary amendment that only prohibits cross-border sales. These amendments will be debated and voted on by the Finance Committee of the Chamber of Deputies in the coming days.
The Italian League party has consistently supported the use of e-cigarettes.
They believe that banning cross-border sales of e-cigarettes alone is a more reasonable and feasible measure as it can limit illegal trade and cross-border circulation, while maintaining a free competition in the domestic market.
It is reported that there are a total of 22,729 registered e-cigarette products in Italy. Of these, 10,322 contain nicotine, while 12,407 are nicotine-free.
The previous Italian government was advocating for reduced harm from tobacco and allowed online sales of e-cigarette products. However, a proposed amendment by a sibling party may potentially change this stance.
Currently, the Italian government and legislature are engaged in heated discussions and debates regarding the sale of e-cigarettes.
They hope to find a balanced solution that both protects public health and promotes economic and market development.
Reference:
The 1038 Bill
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
